OVERVIEW

This course is a comprehensive review of hematologic malignancies focusing on research developments over the preceding year and their application to the patient care journey. Didactic presentations will include case discussion with Penn faculty and community experts. Activity format will provide significant opportunity for interaction with expert faculty and other attendees with the aim of implementing new standards of patient care. Participants will leave with up-to-date, practical information which will have immediate clinical application.

 TARGET AUDIENCE

This activity has been designed for hematologists, medical and radiation oncologists, primary care physicians, pathologists, hematology/oncology fellows, oncology nurses, oncology social workers, and other healthcare professionals involved in the treatment of patients with blood cancer.

LEARNING OBJECTIVES

At the completion of this course, participants should be able to:

• Identify clinical features, including differential diagnoses for the various hematologic malignancies
• Implement strategies that incorporate state-of-the-art genomic analysis for hematologic malignancies
• Identify new data for hereditary myeloid disorders
• Select appropriate hematologic malignancy patients for immunotherapy
• Select appropriate clinical trials for hematologic malignancies
• Identify the major patient management issues experienced by the interprofessional care team associated with hematologic malignancies
• Apply new strategies for incorporating therapies that target metabolism in blood cancers

ACCREDITATION

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credit

PHYSICIANS: Penn Medicine designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.